lifestyle.capitolhilltimes.com

Author: Inovio Pharmaceuticals, Inc.

INOVIO Announces Pricing of $17.5 Million Public Offering

April 2, 2026
INOVIO Announces Proposed Public Offering

April 1, 2026
INOVIO to Participate in Upcoming Scientific Conference

April 1, 2026
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

March 12, 2026
INOVIO to Participate in Upcoming Scientific Conferences

March 9, 2026
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

March 5, 2026
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

March 4, 2026
INOVIO to Participate in Upcoming Scientific and Investor Conferences

February 12, 2026
FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

December 29, 2025
INOVIO Reports Inducement Grant Under Inducement Plan

December 19, 2025